Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US OK for PowrSyringe injector:

This article was originally published in Clinica

Executive Summary

Pinyons Medical Technology has received 510(k) clearance from the US FDA for its PowrSyringe Injector. The product is a disposable, handheld device for injecting contrast media, for example in angiography. "PowrSyringes should deliver the ease-of-use, cost-effective, and tactile feedback characteristics of a syringe, plus the faster injection speed and image quality benefits of electronic power injectors," said the Park City, Utah company's CEO Shawn Fojtik. The faster injection speed can result in lower doses of contrast media. This could mean a reduction in costs for hospitals and a decrease the risk of contrast induced nephropathy - a functional kidney disorder brought on by the use of imaging tracers. The PowrSyringe will become available for sale in early 2008.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel